1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ADAR CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA BTG2 CTRPv2 pan-cancer AAC 0.2 5e-08
mRNA C16orf87 CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA MBD2 CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA SP140 CTRPv2 pan-cancer AAC 0.2 9e-08
mRNA ZNF786 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA SUMO3 CTRPv2 pan-cancer AAC -0.18 1e-07
mRNA IL21R CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA MAP4K1 CTRPv2 pan-cancer AAC 0.23 2e-07
mRNA DDHD1 CTRPv2 pan-cancer AAC 0.19 2e-07
Download CSV